Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr, Murray M, Lange C. Dheda K, et al. Among authors: reuter a. Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2. Nat Rev Dis Primers. 2024. PMID: 38523140 Review.
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB.
Cox V, McKenna L, Acquah R, Reuter A, Wasserman S, Vambe D, Ustero P, Udwadia Z, Triviño-Duran L, Tommasi M, Skrahina A, Seddon JA, Rodolfo R, Rich M, Padanilam X, Oyewusi L, Ohler L, Lungu P, Loveday M, Khan U, Khan P, Hughes J, Hewison C, Guglielmetti L, Furin J. Cox V, et al. Among authors: reuter a. Int J Tuberc Lung Dis. 2020 Nov 1;24(11):1134-1144. doi: 10.5588/ijtld.20.0330. Int J Tuberc Lung Dis. 2020. PMID: 33172520
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
Ismail NA, Omar SV, Moultrie H, Bhyat Z, Conradie F, Enwerem M, Ferreira H, Hughes J, Joseph L, Kock Y, Letsaolo V, Maartens G, Meintjes G, Ngcamu D, Okozi N, Padanilam X, Reuter A, Romero R, Schaaf S, Te Riele J, Variava E, van der Meulen M, Ismail F, Ndjeka N. Ismail NA, et al. Among authors: reuter a. Lancet Infect Dis. 2022 Apr;22(4):496-506. doi: 10.1016/S1473-3099(21)00470-9. Epub 2021 Nov 12. Lancet Infect Dis. 2022. PMID: 34780706
Early mortality during rifampicin-resistant TB treatment.
Mohr-Holland E, Daniels J, Reuter A, Rodriguez CA, Mitnick C, Kock Y, Cox V, Furin J, Cox H. Mohr-Holland E, et al. Among authors: reuter a. Int J Tuberc Lung Dis. 2022 Feb 1;26(2):150-157. doi: 10.5588/ijtld.21.0494. Int J Tuberc Lung Dis. 2022. PMID: 35086627 Free PMC article.
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study.
Cox H, Goig GA, Salaam-Dreyer Z, Dippenaar A, Reuter A, Mohr-Holland E, Daniels J, Cudahy PGT, Nicol MP, Borrell S, Reinhard M, Doetsch A, Beisel C, Gagneux S, Warren RM, Furin J. Cox H, et al. Among authors: reuter a. J Clin Microbiol. 2022 Mar 16;60(3):e0236221. doi: 10.1128/jcm.02362-21. Epub 2022 Mar 16. J Clin Microbiol. 2022. PMID: 35170980 Free PMC article.
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.
Ndjeka N, Campbell JR, Meintjes G, Maartens G, Schaaf HS, Hughes J, Padanilam X, Reuter A, Romero R, Ismail F, Enwerem M, Ferreira H, Conradie F, Naidoo K, Menzies D. Ndjeka N, et al. Among authors: reuter a. Lancet Infect Dis. 2022 Jul;22(7):1042-1051. doi: 10.1016/S1473-3099(21)00811-2. Epub 2022 May 2. Lancet Infect Dis. 2022. PMID: 35512718 Free PMC article.
Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis.
Patankar S, Cruz AT, Douglas-Jones B, Garcia-Prats A, Kay A, Reuter A, Schaaf HS, Seddon JA, Sharma S, Starke J, Tommasi M, Triasih R, Furin JJ. Patankar S, et al. Among authors: reuter a. Am J Respir Crit Care Med. 2023 Jul 15;208(2):130-131. doi: 10.1164/rccm.202304-0670VP. Am J Respir Crit Care Med. 2023. PMID: 37276531 Free PMC article. No abstract available.
288 results